Last $0.0024 USD
Change Today 0.0001 / 4.35%
Volume 1.0M
DROP On Other Exchanges
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

fuse science inc (DROP) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/30/13 - $0.10
52 Week Low
07/25/14 - $0.0021
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FUSE SCIENCE INC (DROP)

fuse science inc (DROP) Related Bloomberg News

View More Bloomberg News

fuse science inc (DROP) Related Businessweek News

View More BusinessWeek News

fuse science inc (DROP) Details

Fuse Science, Inc., a consumer products company, develops alternative delivery systems for energy, medicines, vitamins and minerals, and other pharmaceutical and nutraceutical compounds (bioactives) in the United States. The company is developing sublingual and transdermal delivery systems for bioactives that encapsulate and charge varying molecules to produce product formulations, which are consumed orally, applied topically, or otherwise delivered sublingually or transdermally to bypass the gastrointestinal tract and entering the blood stream directly. It provides EnerJel to address muscle fatigue and soreness before, during, and after physical activity; PowerFuse, an energy formula in a concentrated drop; and ElectroFuse, an electrolyte formula in a concentrated drop. The company was formerly known as Double Eagle Holdings, Ltd. and changed its name to Fuse Science, Inc. in December 2011. Fuse Science, Inc. was founded in 1985 and is headquartered in Miami Lakes, Florida.

6 Employees
Last Reported Date: 01/28/14

fuse science inc (DROP) Top Compensated Officers

Chief Executive Officer, Acting Chief Financi...
Total Annual Compensation: $200.7K
Co-Founder and Consultant
Total Annual Compensation: $81.5K
Total Annual Compensation: $168.4K
Compensation as of Fiscal Year 2013.

fuse science inc (DROP) Key Developments

Fuse Science, Inc. announced delayed 10-Q filing

On 05/15/2014, Fuse Science, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Fuse Science, Inc. Approves Amendment to Articles of Incorporation

Fuse Science, Inc. approved an amendment to the company's Articles of Incorporation to increase the number of shares of common stock at the special meeting of shareholders held on March 19, 2014.

Fuse Science, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2013

Fuse Science, Inc. reported earnings results for the first quarter ended December 31, 2013. For the quarter, the company reported net revenue of $313,993, an increase of 671% as compared to net revenue of $40,711 for the prior year quarter-end December 31, 2012. Loss from operations decreased $579,708 to $1,617,006 for the quarter ended December 31, 2013 as compared to $2,196,714 for the quarter period ended December 31, 2012. Excluding non-cash charges, loss from operations decreased $549,927 to $495,737 as compared to $1,045,664 for the quarter ended December 31, 2012.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DROP:US $0.00 USD 0.0001

DROP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Johnson & Johnson $101.96 USD -0.15
PepsiCo Inc $90.14 USD -0.83
View Industry Companies

Industry Analysis


Industry Average

Valuation DROP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FUSE SCIENCE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at